Malignant Hematology Fellowship Program

Malignant Hematology Fellowship Program


The Malignant Hematology Fellowship Program at the Stanford Cancer Institute offers advanced clinical training and dedicated research opportunities in malignant hematologic disorders. Administered by the Division of Hematology, the program is designed for physicians pursuing academic careers with a focus on clinical and/or translational research in malignant hematology.

The fellowship provides specialized training through focused tracks in multiple myeloma and acute leukemia, with an emphasis on comprehensive patient care, clinical investigation, and translational research.

Advanced Multiple Myeloma Fellowship

The CKD Family Fellowship is an advanced training program in multiple myeloma at the Stanford Cancer Institute, offering comprehensive clinical training and dedicated research opportunities in multiple myeloma and related plasma cell disorders.

The program emphasizes the clinical management and investigation of:

  • Multiple myeloma
  • Immunoglobulin light chain (AL) amyloidosis
  • Waldenström macroglobulinemia
  • Related plasma cell dyscrasias

 

Its primary goal is to prepare fellows for careers focused on the care of patients with plasma cell disorders and the conduct of impactful clinical and translational research.

Advanced Acute Leukemia Fellowship

The Acute Leukemia Fellowship is an advanced training program at the Stanford Cancer Institute focused on acute leukemia and related hematologic malignancies.

The program provides comprehensive clinical training and dedicated research opportunities in:

  • Acute leukemia
  • Myelodysplastic syndrome (MDS)

 

The fellowship emphasizes the clinical management and investigation of acute leukemia and prepares fellows for academic careers centered on patient care, clinical investigation, and translational research.

Fellowship Appointment

Fellows in both programs will be appointed as Clinical Fellows in Medicine at the Stanford School of Medicine.

Program Launch

The Malignant Hematology Fellowship Program will begin in July 2026.